Multiple post-hoc comparison showed a significantly lower FoF1-ATPase activity and ADP/O ratio for vehicle-treated 3 × Tg-AD mice compared to non-Tg mice that was counteracted by um-PEA treatment (Figures 2B,F). This evidence concerns the gene DNAH8 and Alzheimer disease.